Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study
Shunsuke Furuta, Daiki Nakagomi, Y Kobayashi, Masaki Hiraguri, Takao Sugiyama, Koichi Amano, Takeshi Umibe, Hajime Kono, Kazuhiro Kurasawa, Yasuhiko Kita, Ryutaro Matsumura, Yuko Kaneko, Keita Ninagawa, Keiju Hiromura, Shin‐ichiro Kagami, Yosuke Inaba, Hideki Hanaoka, Kei Ikeda, Hiroshi Nakajima
Topics & Concepts
MedicineRituximabPrednisoloneInternal medicineVasculitisGastroenterologyAdverse effectAnti-neutrophil cytoplasmic antibodyCorticosteroidPrednisoneSurgeryMaintenance doseMethylprednisoloneLymphomaDiseaseVasculitis and related conditionsSystemic Sclerosis and Related DiseasesAutoimmune Bullous Skin Diseases